MYBPC3 non-truncating variants in HCM cohorts


The table below lists the 272 rare (MAF<0.0001 in ExAC) non-truncating MYBPC3 variants identified in a cohort of 2912 HCM patients. When this rare variant frequency of 0.09341 is compared with a background population rate of 0.01884, there is a statistically significant case excess of 0.07457 (p<0.0001), which suggests that approximately 218 of these variants may be pathogenic.


Variant Type:      All protein-altering variants     -     Truncating variants     -     Non-Truncating variants
Source:      Combined (OMGL + LMM)     -     OMGL     -     LMM



No. Variant (CDS) Variant (Protein) Variant Type Cases (2912)LMM class ExAC frequency
1. c.2518G>A p.V840Mmissense 1VUS0.000016
2. c.1672G>A p.A558Tmissense 1VUS0.000008
3. c.2312T>C p.V771Amissense 1VUS0.000000
4. c.3083C>G p.T1028Smissense 1VUS0.000000
5. c.3415G>A p.V1139Imissense 1VUS0.000087
6. c.2210C>T p.T737Mmissense 1VUS0.000050
7. c.373G>T p.A125Smissense 1VUS0.000000
8. c.1586C>G p.T529Smissense 1VUS favour pathogenic0.000000
9. c.2436G>T p.K812Nmissense 1VUS0.000000
10. c.2723A>G p.Y908Cmissense 1VUS0.000062
11. c.1934C>T p.P645Lmissense 2VUS0.000000
12. c.2459G>A p.R820Qmissense 1Likely Pathogenic0.000016
13. c.355G>A p.E119Kmissense 3VUS0.000000
14. c.2374T>C p.W792Rmissense 5Likely Pathogenic0.000000
15. c.442G>A p.G148Rmissense 7VUS favour pathogenic0.000042
16. c.772G>A p.E258Kmissense 21Pathogenic0.000039
17. c.1591G>C p.G531Rmissense 1VUS favour pathogenic0.000017
18. c.3064C>T p.R1022Cmissense 4VUS favour pathogenic0.000008
19. c.3797G>A p.C1266Ymissense 1Likely Pathogenic0.000000
20. c.2882C>T p.P961Lmissense 2VUS0.000048
21. c.1483C>T p.R495Wmissense 2VUS favour pathogenic0.000000
22. c.2269G>A p.V757Mmissense 1VUS0.000066
23. c.1960C>T p.R654Cmissense 1VUS favour benign0.000008
24. c.932C>T p.S311Lmissense 1VUS0.000000
25. c.1397T>A p.M466Kmissense 1VUS0.000008
26. c.2197C>T p.R733Cmissense 1VUS0.000085
27. c.2828G>A p.R943Qmissense 1VUS0.000025
28. c.104G>A p.R35Qmissense 1VUS0.000079
29. c.3548T>G p.F1183Cmissense 1Likely Pathogenic0.000000
30. c.451G>A p.D151Nmissense 1VUS0.000041
31. c.1505G>T p.R502Lmissense 1VUS favour pathogenic0.000000
32. c.326C>T p.A109Vmissense 1VUS0.000000
33. c.1188G>T p.W396Cmissense 1VUS0.000000
34. c.436A>C p.T146Pmissense 1VUS0.000000
35. c.290C>T p.A97Vmissense 1VUS favour pathogenic0.000000
36. c.1483C>G p.R495Gmissense 4Likely Pathogenic0.000000
37. c.931T>A p.S311Tmissense 1VUS0.000000
38. c.2429G>A p.R810Hmissense 8VUS favour pathogenic0.000033
39. c.1343T>C p.F448Smissense 1Likely Pathogenic0.000000
40. c.2573G>A p.S858Nmissense 4VUS favour pathogenic0.000000
41. c.2450G>A p.R817Qmissense 3VUS favour pathogenic0.000016
42. c.1504C>T p.R502Wmissense 45Pathogenic0.000024
43. c.814C>T p.R272Cmissense 2VUS0.000083
44. c.1778C>T p.S593Fmissense 1VUS favour pathogenic0.000034
45. c.2560A>G p.M854Vmissense 1VUS0.000000
46. c.713G>A p.R238Hmissense 1VUS0.000074
47. c.3746G>T p.G1249Vmissense 1VUS0.000000
48. c.3605G>A p.C1202Ymissense 1Likely Pathogenic0.000000
49. c.3098G>A p.R1033Qmissense 1VUS0.000000
50. c.2320G>A p.A774Tmissense 2VUS0.000000
51. c.2939G>A p.R980Hmissense 1VUS0.000000
52. c.1841A>G p.Y614Cmissense 1VUS favour pathogenic0.000000
53. c.2449C>T p.R817Wmissense 1VUS0.000000
54. c.1950C>G p.D650Emissense 1VUS0.000000
55. c.3373G>A p.V1125Mmissense 1VUS favour pathogenic0.000022
56. c.518C>A p.T173Nmissense 1VUS0.000000
57. c.655G>C p.V219Lmissense 8Likely Pathogenic0.000000
58. c.1456T>G p.W486Gmissense 1Likely Pathogenic0.000000
59. c.1484G>A p.R495Qmissense 10VUS favour pathogenic0.000008
60. c.3580G>A p.A1194Tmissense 1VUS0.000008
61. c.532G>A p.V178Mmissense 2VUS favour pathogenic0.000020
62. c.3763G>A p.A1255Tmissense 1VUS favour pathogenic0.000075
63. c.2234A>G p.D745Gmissense 1VUS0.000000
64. c.1213A>G p.M405Vmissense 1Pathogenic0.000000
65. c.1540A>G p.I514Vmissense 1VUS0.000008
66. c.2873C>T p.T958Imissense 3VUS favour benign0.000065
67. c.1828G>C p.D610Hmissense 2VUS favour benign0.000058
68. c.2938C>T p.R980Cmissense 1VUS0.000062
69. c.2170C>T p.R724Wmissense 1VUS0.000019
70. c.3676C>T p.R1226Cmissense 1VUS0.000058
71. c.1358C>T p.P453Lmissense 1VUS0.000008
72. c.3049G>A p.E1017Kmissense 1VUS favour benign0.000085
73. c.1535T>A p.L512Qmissense 1VUS favour pathogenic0.000000
74. c.1294G>A p.A432Tmissense 1VUS0.000037
75. c.2557G>A p.G853Smissense 1VUS0.000008
76. c.2308G>A p.D770Nmissense 6Likely Pathogenic0.000008
77. c.853G>A p.D285Nmissense 1VUS0.000000
78. c.3065G>A p.R1022Hmissense 1VUS favour pathogenic0.000000
79. c.3281A>T p.N1094Imissense 1VUS0.000000
80. c.1418T>C p.F473Smissense 1VUS0.000000
81. c.1505G>A p.R502Qmissense 6Pathogenic0.000000
82. c.1591G>A p.G531Rmissense 3VUS favour pathogenic0.000017
83. c.3065G>C p.R1022Pmissense 1VUS favour pathogenic0.000025
84. c.2671C>T p.R891Wmissense 1Likely Pathogenic0.000031
85. c.2641G>A p.V881Imissense 1VUS0.000018
86. c.636C>G p.S212Rmissense 2VUS favour pathogenic0.000000
87. c.3742G>A p.G1248Rmissense 1VUS0.000033
88. c.103C>T p.R35Wmissense 1VUS0.000056
89. c.2654C>T p.T885Mmissense 1VUS0.000022
90. c.1828G>A p.D610Nmissense 3VUS0.000000
91. c.3791G>A p.C1264Ymissense 1VUS0.000008
92. c.3G>C p.Met1?missense 1Likely Pathogenic0.000000
93. c.3277G>T p.G1093Cmissense 1VUS0.000020
94. c.2525A>G p.Y842Cmissense 1VUS0.000000
95. c.1037G>A p.R346Hmissense 2VUS0.000000
96. c.3413G>C p.R1138Pmissense 1VUS0.000000
97. c.2533C>T p.R845Cmissense 1VUS favour pathogenic0.000000
98. c.566T>A p.V189Dmissense 1VUS0.000000
99. c.1624G>C p.E542Qmissense 17Likely Pathogenic0.000024
100. c.710A>C p.Y237Smissense 3Likely Pathogenic0.000000
101. c.223G>A p.D75Nmissense 1VUS favour pathogenic0.000091
102. c.2993A>G p.Q998Rmissense 1VUS favour pathogenic0.000000
103. c.1790G>A p.R597Qmissense 2VUS favour pathogenic0.000000
104. c.844C>T p.R282Wmissense 1VUS favour pathogenic0.000000
105. c.1021G>A p.G341Smissense 1VUS favour pathogenic0.000025
106. c.481C>A p.P161Tmissense 1VUS favour pathogenic0.000041
107. c.1766G>A p.R589Hmissense 2VUS0.000000
108. c.2528_2536delAGATGCGCG p.Glu843_Arg845delinframe 1Pathogenic0.000000
109. c.1513_1515delAAG inframe 2VUS favour pathogenic0.000000
110. c.3767_3769delCCA p.Thr1256delinframe 3Likely Pathogenic0.000000
111. c.3742_3759dup p.Gly1248_Cys1253dupinframe 4Likely Pathogenic0.000000

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.

2. Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, Cox SW, DePalma SR, Ho CY, Seidman JG, Seidman CE, Rehm HL. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med. 2015 Nov;17(11):880-8.